Search details
1.
Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.
Thyroid
; 32(2): 153-163, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34641722
2.
Gammadelta T lymphocyte homeostasis is negatively regulated by beta2-microglobulin.
J Immunol
; 182(4): 1892-900, 2009 Feb 15.
Article
in English
| MEDLINE | ID: mdl-19201842
3.
Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.
Nat Rev Endocrinol
; 16(11): 629-641, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32839578
4.
Comprehensive Immune Profiling of Medullary Thyroid Cancer.
Thyroid
; 30(9): 1263-1279, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32242507
5.
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.
J Clin Endocrinol Metab
; 105(1)2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31513709
6.
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Clin Cancer Res
; 24(13): 3059-3068, 2018 07 01.
Article
in English
| MEDLINE | ID: mdl-29615459
7.
Leveraging the immune system to treat advanced thyroid cancers.
Lancet Diabetes Endocrinol
; 5(6): 469-481, 2017 06.
Article
in English
| MEDLINE | ID: mdl-27773653
8.
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.
J Clin Endocrinol Metab
; 101(7): 2863-73, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27045886
9.
Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.
Oncogene
; 22(23): 3598-607, 2003 Jun 05.
Article
in English
| MEDLINE | ID: mdl-12789268
10.
PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
Cancer Immunol Res
; 3(6): 620-30, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25701326
11.
Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers.
Thyroid
; 23(5): 529-42, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23317509
12.
Thyroid cancer: CAR T cell therapy - potential in advanced thyroid cancer?
Nat Rev Endocrinol
; 14(1): 10-11, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29170541
13.
Influence of human immune cells on cancer: studies at the University of Colorado.
Immunol Res
; 55(1-3): 22-33, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22941561
14.
Thyroid-Specific T Cells in Patients With Differentiated Thyroid Cancer: Implications for Immune-Based Therapies?
J Clin Endocrinol Metab
; 102(7): 2131-2132, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-28899074
15.
Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer.
J Clin Endocrinol Metab
; 97(6): E934-43, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22466343
16.
Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
J Clin Endocrinol Metab
; 95(5): 2325-33, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20207826
17.
Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.
J Clin Endocrinol Metab
; 94(6): 2199-203, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19293266
18.
gammadelta T lymphocytes-selectable cells within the innate system?
J Clin Immunol
; 27(2): 133-44, 2007 Mar.
Article
in English
| MEDLINE | ID: mdl-17333410
19.
Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells.
J Immunol
; 179(8): 5576-83, 2007 Oct 15.
Article
in English
| MEDLINE | ID: mdl-17911645
20.
Airway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells.
J Immunol
; 179(5): 2961-8, 2007 Sep 01.
Article
in English
| MEDLINE | ID: mdl-17709511